You are here

CL-108

Daiichi Sankyo punts $650M collaboration pact as Charleston Labs preps a comeback attempt on spurned pain drug

Endpoints

Thu, 08/31/17 - 09:13 am

Charleston Laboratories

Daiichi Sankyo bets up to $650M on Charleston's pain potential

Fierce Biotech

Thu, 08/7/14 - 09:51 am

Charleston Laboratories